The study reported that by mediating YTHDF1’s overexpression, ELK1 is implicated in the expression of polo-like kinase 1 (PLK1), which promotes cell cycle progression and contributed to tumor growth and chemoresistance [152]. The gene discussed is PLK1; the disease is neoplasm.